Literature DB >> 21042788

Investigation of angiogenetic axis Angiopoietin-1 and -2/Tie-2 in fibrotic lung diseases: a bronchoalveolar lavage study.

Giorgos A Margaritopoulos1, Katerina M Antoniou, Kostas Karagiannis, Evi Vassalou, Ismini Lasithiotaki, Irini Lambiri, Nikos M Siafakas.   

Abstract

Increasing evidence implicates angiogenesis in the pathogenesis of fibrotic lung diseases. Distinct angiogenic profiles may, in part, explain differences in immunopathogenesis, clinical course and prognosis. The aim of the study was to seek evidence of involvement of the angiogenic axis Angiopoietin-1 and -2 and their tyrosine kinase receptor, Tie-2 in pathogenesis of idiopathic pulmonary fibrosis (IPF) and interstitial pneumonias associated to collagen tissue disorders (CTD-IPs). We prospectively studied 36 patients with IPF, 23 patients with CTD-IP and 10 healthy subjects. Ang-1, Ang-2 and Tie-2 mRNA expression and protein levels were measured in bronchoalveolar lavage fluid pellets and supernatants, respectively. A statistically significant decrease of Ang-1 protein level has been found in IPF in comparison to controls (p=0.02). We also detected an increased expression of Ang-2 protein in IPF in comparison to CTD-IPs. A significant co-expression was detected between Ang-2 and Tie-2 in protein level (p=0.007) in IPF group. In conclusion, a suppression of the angiogenetic factor Ang-1 was observed at the protein level in IPF which may be important in the pathogenesis of this devastating disease. A differential angiogenetic profile regarding Ang-2 was detected between IPF and CTD-IPs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042788     DOI: 10.3892/ijmm_00000543

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  S Barratt; A Millar
Journal:  QJM       Date:  2014-01-22

2.  Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Dariusz Ziora; Dariusz Jastrzębski; Mariusz Adamek; Zenon Czuba; Jerzy J Kozielski; Alicja Grzanka; Alicja Kasperska-Zajac
Journal:  BMC Pulm Med       Date:  2015-10-05       Impact factor: 3.317

3.  Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression.

Authors:  Tadanori Mammoto; Elisabeth Jiang; Amanda Jiang; Yongbo Lu; Aimee M Juan; Jing Chen; Akiko Mammoto
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

4.  Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.

Authors:  Joshua M Diamond; Mary K Porteous; Edward Cantu; Nuala J Meyer; Rupal J Shah; David J Lederer; Steven M Kawut; James Lee; Scarlett L Bellamy; Scott M Palmer; Vibha N Lama; Sangeeta M Bhorade; Maria Crespo; Ejigayehu Demissie; Keith Wille; Jonathan Orens; Pali D Shah; Ann Weinacker; David Weill; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

5.  Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

Authors:  Shanna L Ashley; Meng Xia; Susan Murray; David N O'Dwyer; Ethan Grant; Eric S White; Kevin R Flaherty; Fernando J Martinez; Bethany B Moore
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.